B
BOLD
BOUNDLESS BIO INC
1.560
+0.360+30.00%After Hours: 1.540 -0.020 -1.28%19:59 04/14 EDT
OPEN/PREV CLOSE1.460/1.200
TODAY RANGE1.400-1.680
VOL6.07M
MARKET CAP34.96M
52 WEEK RANGE0.9612-1.780
AVG VOL (3M)215.39K
% TURNOVER27.09%
TURNOVER--
P/E (TTM)-0.5994
% RANGE22.96%
EPS(TTM)-2.6027
P/E(FORWARD)-0.6667
P/B0.3543
BVPS4.403
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP30.98M
SHARES OUTSTANDING22.41M
NEXT EARNINGS05/07-05/11
FREE FLOAT19.86M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
Boundless Bio Terminates Major Long-Term San Diego Lease
Seeking Alpha·03/20 07:25
Boundless Bio: An Underestimated Biotech With A First-In-Class EcDNA Targeted Kinesin Degrader
TipRanks·03/10 11:17
Boundless Bio Inc. (BOLD) Receives a Hold from Guggenheim
TipRanks·03/09 11:06
Boundless Bio reports Q4 EPS (58c), consensus (52c)
TipRanks·03/09 11:06
Boundless Bio sees cash runway into 2H28
Seeking Alpha·03/09 11:06
Boundless Bio GAAP EPS of -$0.58 misses by $0.12
Reuters·03/09 11:00
BOUNDLESS BIO INC - Q4 EPS $-0.58
TipRanks·02/12 16:31
Boundless Bio Advances New Breast Cancer Drug BBI-940 Into First-in-Human Trial
Same Industry
Name/Symbol
Change%
Price